Understanding Sjogren's syndrome through the neurologist's eye

Year 2021, Volume: 5 Issue: 5, 556 - 559, 01.05.2021

Yaşar Altun , Haci Bulut Ali Arık

https://doi.org/10.28982/josam.760513

Abstract

Sjögren’s syndrome (SS) is an autoimmune disease characterized by mononuclear cell infiltration and destruction of the lacrimal and salivary glands, which causes dryness of the eyes and mouth. It has a wide clinical spectrum. It can manifest as focal lesions, including focal or motor deficits, stroke, or cerebellar syndromes. Central nervous system involvement should be kept in mind in patients with SS, as it may have serious consequences. Herein, we report a 60-year-old female patient who was misdiagnosed with cerebrovascular disease in the emergency department.

Keywords

Sjögren’s syndrome, Autoimmune disorder, Stroke

Supporting Institution

None

Project Number

None

References

• 1. Goules AV, Tzioufas AG, Moutsopoulos HM. Classification criteria of Sjögren's syndrome. J Autoimmun. 2014;48-49:42-5.
• 2. Leone MC, Alunno A, Cafaro G, Valentini V, Marcucci E, Bartoloni E, et al. The clinical spectrum of primary Sjögren's syndrome: beyond exocrine glands. Rheumatism. 2017;69:93-100.
• 3. Daniels TE, Fox PC. Salivary and oral components of Sjögren’s syndrome. Rheum Clin Dis North Am. 1992;18:571-89.
• 4. Gono T, Kawaguchi Y, Katsumata Y, Tagaki K, Tochimoto A, Baba S, et al. Clinical manifestations of neurological involvement in primary Sjögren’s syndrome. Clin Rheumatol. 2011;30:485-90.
• 5. Moutsopoulos HM. Sjögren’s Syndrome. In: Kasper DL, Fauci AS, Longo DL, Braunwald E, Hauser SL, Jameson JL, eds. Harrison’s principles of internal medicine. 16th ed. New York, NY: McGraw-Hill Medical Publishing Division; 2005, pp. 1990-1993.
• 6. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. European Study Group on Classification Criteria for Sjögren’s Syndrome. Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61:554-8.
• 7. Urban PP, Keilmann A, Teichmann EM, Hopf HC. Sensory neuropathy of the trigeminal, glossopharyngeal, and vagal nerves in Sjögren’s syndrome. J of Neurological Sciences. 2001;186:59-63.
• 8. Tzioufas AG, Manoussakis MN, Costello R, Silis M, Papadopoulos NM, Moutsopoulos HM. Cryoglobulinemia in autoimmune rheumatic diseases. Evidence of circulating monoclonal cryoglobulins in patients with primary Sjögren’s syndrome. Arthritis Rheum. 1986;29:1089-104.
• 9. Le Goff M, Cornec D, Jousse-Joulin S, Guellec D, Costa S, Marhadour T, et al. Comparison of 2002 AECG and 2016 ACR/ EULAR classification criteria and added value of salivary gland ultrasonography in a patient cohort with suspected primary Sjögren's syndrome. Arthritis Res Ther. 2017;19:269.
• 10. Segal B, Carpenter A, Walk D. Involvement of nervous system pathways in primary Sjögren’s syndrome. Rheum Dis Clin North Am. 2008;34:885-906.
• 11. Grant IA, Hunder GG, Homburger HA, Dyck PJ. Peripheral neuropathy associated with sicca complex. Neurology. 1997;48:855-62.
• 12. Gemignani F, Marbini A, Pavesi G, Di Vittorio S, Manganelli P, Cenacchi G, et al. Peripheral neuropathy associated with primary Sjogren’s syndrome. J Neurol Neurosurg Psychiatry. 1994;57:983-6.
• 13. Theander E, Jonsson R, Sjöström B, Brokstad K, Olsson P, Henriksson G. Prediction of Sjögren's Syndrome Years Before Diagnosis and Identification of Patients With Early Onset and Severe Disease Course by Autoantibody Profiling. Arthritis Rheumatol. 2015;67:2427-36.
• 14. Guellec D, Cornec D, Jousse-Joulin S, Marhadour T, Marcorelles P, Pers JO, et al. Diagnostic value of labial minor salivary gland biopsy for Sjögren's syndrome: a systematic review. Autoimmun Rev. 2013;12:416-20.
• 15. Lafitte C, Amoura Z, Cacoub P, Paradat-Dihl P, Picq C, Salachas F, et al. Neurological complications of primary Sjögren's syndrome. J Neurol. 2001;248:577-84.
• 16. Yamamoto K: Pathogenesis of Sjögren's syndrome. Autoimmunity Reviews. 2003;2:13-8.
• 17. Delalande S, Seze J, Fauchais AL, Hachulla E, Stojkovic T, Ferriby D, et al. Neurologic manifestations in primary Sjögren's syndrome. Medicine. 2004;83:280-91.
• 18. Coates T, Slavotinek JP, Rischmueller M, Schultz D, Anderson C, Dellamelva M, et al: Cerebral white matter lesions in primary Sjögren's syndrome: a controlled study. J Rheumatol. 1999;26:1301-5.
• 19. Chiang CH, Liu CJ, Chen PJ, Huang CC, Hsu CY, Chan WL, et al. Primary Sjogren’s syndrome and risk of ischemic stroke: a nationwide study. Clin Rheumatol. 2014;33(7):931-7.
• 20. Pasoto SG, Chakkour HP, Natalino RR, Viana VS, Bueno C, Lianza AC, et al. Lupus anticoagulant: a marker for stroke and venous thrombosis in primary Sjogren’s syndrome. Clin Rheumatol. 2012;31(9):1331-8.
• 21. Mariette X: Current and potential treatments for primary Sjögren's syndrome. Joint Bone Spine. 2002;69:363-6.